诺瓦瓦克斯医药(NVAX)涨11.77% 公司新冠疫苗已在全国数千家门店供应

金吾财讯
02 Oct 2024

金吾财讯 | 诺瓦瓦克斯医药(NVAX)股价震荡走高,截止发稿,涨11.77%,报13.77美元,成交额7867.76万美元。

消息面上,此前公司宣布其2024-2025年版COVID-19生物-疫苗现已在全国数千家门店提供。杰富瑞集团维持公司买入评级及目标价31美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10